Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-025382

Chief Operating Officer sold 23,515 shares at $40.00 ($940,600)

  • Chief Operating Officer acquired 16,256 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GIVEN BRUCE D Chief Operating Officer 2020-04-20 Option exercise +3,800 $4.75 $18,050 862,793 D
GIVEN BRUCE D Chief Operating Officer 2020-04-20 Option exercise +3,700 $5.19 $19,203 866,493 D
GIVEN BRUCE D Chief Operating Officer 2020-04-20 Option exercise +3,456 $5.20 $17,971 869,949 D
GIVEN BRUCE D Chief Operating Officer 2020-04-20 Option exercise +5,300 $14.54 $77,062 875,249 D
GIVEN BRUCE D Chief Operating Officer 2020-04-20 Sale −3,800 $40.00 $152,000 871,449 D
GIVEN BRUCE D Chief Operating Officer 2020-04-20 Sale −3,700 $40.00 $148,000 867,749 D
GIVEN BRUCE D Chief Operating Officer 2020-04-20 Sale −3,456 $40.00 $138,240 864,293 D
GIVEN BRUCE D Chief Operating Officer 2020-04-20 Sale −5,300 $40.00 $212,000 858,993 D
GIVEN BRUCE D Chief Operating Officer 2020-04-20 Sale −3,454 $40.00 $138,160 855,539 D
GIVEN BRUCE D Chief Operating Officer 2020-04-20 Sale −3,805 $40.00 $152,200 851,734 D
Derivatives
GIVEN BRUCE D Chief Operating Officer 2020-04-20 Option exercise · Stock Option (right to buy) −3,800 346,200 D
GIVEN BRUCE D Chief Operating Officer 2020-04-20 Option exercise · Stock Option (right to buy) −3,700 342,500 D
GIVEN BRUCE D Chief Operating Officer 2020-04-20 Option exercise · Stock Option (right to buy) −3,456 339,044 D
GIVEN BRUCE D Chief Operating Officer 2020-04-20 Option exercise · Stock Option (right to buy) −5,300 333,744 D
Open-market sales · 23,515 sh · avg $40.00 · $940,600
Loading xslF345X03/doc4.xml…